The experts questioned the rationale for annual shots ... FDA vaccine officer, said his “gut feeling” was that a vaccine ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The U.S. Food and Drug Administration vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...